Having been setup in 2012, Artemis Pharma Ltd has its registered office in London, it has a status of "Active". Greaves, Mark Raymond is listed as the only a director of the company. Currently we aren't aware of the number of employees at the the company.
Director Name | Appointed | Resigned | Total Appointments |
---|---|---|---|
GREAVES, Mark Raymond | 06 March 2012 | 03 April 2013 | 1 |
Document Type | Date | |
---|---|---|
AA - Annual Accounts | 21 November 2019 | |
CS01 - N/A | 28 October 2019 | |
PSC08 - N/A | 28 October 2019 | |
PSC07 - N/A | 28 October 2019 | |
CS01 - N/A | 17 October 2019 | |
AP01 - Appointment of director | 17 October 2019 | |
TM01 - Termination of appointment of director | 17 October 2019 | |
AD01 - Change of registered office address | 17 October 2019 | |
TM02 - Termination of appointment of secretary | 17 October 2019 | |
CS01 - N/A | 19 March 2019 | |
AA - Annual Accounts | 20 December 2018 | |
CS01 - N/A | 14 March 2018 | |
TM01 - Termination of appointment of director | 14 February 2018 | |
AP01 - Appointment of director | 14 February 2018 | |
AA - Annual Accounts | 02 January 2018 | |
CS01 - N/A | 24 April 2017 | |
AA - Annual Accounts | 13 December 2016 | |
AR01 - Annual Return | 08 March 2016 | |
CH01 - Change of particulars for director | 05 January 2016 | |
AA - Annual Accounts | 21 December 2015 | |
AR01 - Annual Return | 01 April 2015 | |
AA - Annual Accounts | 31 October 2014 | |
AR01 - Annual Return | 24 March 2014 | |
AP01 - Appointment of director | 02 December 2013 | |
TM01 - Termination of appointment of director | 02 December 2013 | |
AA - Annual Accounts | 16 September 2013 | |
AP01 - Appointment of director | 03 April 2013 | |
TM01 - Termination of appointment of director | 03 April 2013 | |
AR01 - Annual Return | 06 March 2013 | |
CH01 - Change of particulars for director | 06 March 2013 | |
CH04 - Change of particulars for corporate secretary | 06 March 2013 | |
AD01 - Change of registered office address | 09 November 2012 | |
NEWINC - New incorporation documents | 06 March 2012 |